Journal article
An AI-based approach for modeling the synergy between radiotherapy and immunotherapy
Abstract
Personalized, ultra-fractionated stereotactic adaptive radiotherapy (PULSAR) is designed to administer tumoricidal doses in a pulsed mode with extended intervals, spanning weeks or months. This approach leverages longer intervals to adapt the treatment plan based on tumor changes and enhance immune-modulated effects. In this investigation, we seek to elucidate the potential synergy between combined PULSAR and PD-L1 blockade immunotherapy using …
Authors
Peng H; Moore C; Zhang Y; Saha D; Jiang S; Timmerman R
Journal
Scientific Reports, Vol. 14, No. 1,
Publisher
Springer Nature
DOI
10.1038/s41598-024-58684-6
ISSN
2045-2322